Day: May 23, 2024

Inari Medical Files Patent Infringement Lawsuit Against Imperative Care and Truvic Medical

IRVINE, Calif., May 23, 2024 (GLOBE NEWSWIRE) — Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company with a mission to treat and transform the lives of patients suffering from venous and other diseases, announced today that it had filed a patent infringement lawsuit against Imperative Care, Inc. and Truvic Medical, Inc. (collectively, “Truvic”). The suit was filed in the United States District Court for the Northern District of California. Inari is seeking injunctive relief and damages for infringement. Inari believes Truvic is infringing eight of Inari Medical’s patents for the use of aspiration-based thrombectomy devices to treat pulmonary emboli and deep vein thrombosis. Truvic products named in the suit include the Symphony Thrombectomy System. “Inari was founded to improve patients’ lives using purpose-built...

Continue reading

Mission Produce™ to Release Fiscal Second Quarter 2024 Financial Results on Thursday, June 6, 2024

OXNARD, Calif., May 23, 2024 (GLOBE NEWSWIRE) — Mission Produce, Inc. (Nasdaq: AVO) (“Mission” or the “Company”), a world leader in sourcing, producing, and distributing fresh Hass avocados with additional offerings in mangos and blueberries, today announced it will release its financial results for the fiscal second quarter ended April 30, 2024 after the market closes on Thursday, June 6, 2024. The Company will host a conference call and webcast to discuss its financial results at 5:30 PM Eastern Time on the same day. Conference Call Details The conference call can be accessed live over the phone by dialing (877) 407-9039 or for international callers by dialing (201) 689-8470. A replay of the call will be available through June 20, 2024 by dialing (844) 512-2921 or for international callers by dialing (412) 317-6671; the passcode...

Continue reading

Global Study Finds Consumers Are Open to AI Companions BUT Are Worried About Maintaining Human Connections

New York, NY, May 23, 2024 (GLOBE NEWSWIRE) — Momentum Worldwide, a global experiential marketing agency that is part of Interpublic Group (NYSE: IPG), has released the findings of a global study that uncovers consumers’ willingness to use AI to connect with each other and the world around them, as 93% encounter difficulty making new friends or joining new communities. The Connecting Consumers report by Momentum Worldwide found technology is seen as an enabler to connections, with 46% open to an AI or augmented-reality companion that offers advice and companionship. However, there is caution around technology with 88% saying there is room for advanced technology in their lives if it doesn’t take over, and 70% worried human connections will be lost as AI continues to grow. This reflects a deeper implication: with the rise...

Continue reading

Byrna Technologies Adds Three Additional Media Influencers Launching in June

ANDOVER, Mass., May 23, 2024 (GLOBE NEWSWIRE) — Byrna Technologies Inc. (“Byrna” or the “Company”) (Nasdaq: BYRN), a personal defense technology company specializing in the development, manufacture, and sale of innovative less-lethal personal security solutions, today announced strategic partnerships with three additional media personalities. These partnerships aim to further broaden Byrna’s reach and champion its mission to promote safer personal security solutions. Through these partnerships, Byrna is set to be featured on the following terrestrial radio and podcasts through live and voice reads, with the aim of enhancing its visibility and consumer engagement. Dan Bongino’s “The Dan Bongino Show”, syndicated through Westwood One, is available on terrestrial radio and podcast platforms, reaching over 400,000 individuals daily...

Continue reading

Horizon Aircraft Announces Participation in the 2nd Annual Jefferies eVTOL / AAM Summit

TORONTO, May 23, 2024 (GLOBE NEWSWIRE) — New Horizon Aircraft Ltd. (NASDAQ: HOVR), doing business as Horizon Aircraft (“Horizon Aircraft” or the “Company”), a leading hybrid electric Vertical TakeOff and Landing (“eVTOL”) aircraft developer, announced today that the Company will participate in a virtual fireside chat during the Jefferies eVTOL / AAM Summit on Thursday, May 30, 2024 at 9:10am Eastern Time. In addition, Horizon Aircraft’s management team will be available for virtual one-on-one meetings during the event. To schedule a meeting with Horizon Aircraft’s management team, please contact your Jefferies representative or Horizon Aircraft’s Investor Relations at HorizonAircraft@mzgroup.us. To access the live webcast of Horizon Aircraft’s fireside chat, please click here. A replay of the fireside chat will be available on...

Continue reading

XWELL Continues to Innovate in Airport Wellness Space with New Massage Solutions: Introducing Ceragem V6 in select XpresSpa® Locations in US

Expanded service offering underscores XWELL’s ongoing focus on delivering cost-effective wellness services that drive top-line growth NEW YORK, May 23, 2024 (GLOBE NEWSWIRE) — XWELL, Inc. (Nasdaq: XWEL) (“XWELL” or the “Company”), an authority in wellness solutions for people on the go, today announced plans to introduce the Ceragem V6 Therapeutic Thermal Massager in select XpresSpa locations beginning in the second quarter of 2024. The fully autonomous and innovative massage solution is designed to rejuvenate and revolutionize relaxation by providing enhanced blood circulation, muscle and joint discomfort, as well as muscle relaxation. “We are excited to introduce this cutting-edge massage solution to travelers,” commented XWELL Chief Executive Officer, Scott Milford. “This offering reflects our ongoing commitment...

Continue reading

Cellebrite Announces First-Quarter 2024 Results

ARR of $331.8 million, up 27% year-over-year;  Q1 2024 revenue of $89.6 million, up 26% year-over-year primarily due to 29% growth in subscription revenue;  Q1 2024 adjusted EBITDA of $17.6 million, 19.7% adjusted EBITDA margin TYSONS CORNER, Va. and PETAH TIKVA, Israel, May 23, 2024 (GLOBE NEWSWIRE) — Cellebrite (NASDAQ: CLBT), a global leader in premier Digital Investigative solutions for the public and private sectors, today announced financial results for the three months ending March 31, 2024. “Cellebrite is off to a very solid start to 2024 as we continued to grow wallet share with existing customers around the world,” said Yossi Carmil, Cellebrite’s CEO. “Our strong first-quarter performance was anchored by the further expansion of our business around the globe, improved profitability versus the same quarter one year ago...

Continue reading

Sono-Tek Announces Fiscal Year 2024 Results with Record-Breaking Revenue and Record YOY Backlog

MILTON, N.Y., May 23, 2024 (GLOBE NEWSWIRE) — Sono-Tek Corporation (NASDAQ: SOTK), the leading developer and manufacturer of ultrasonic coating systems, today reported financial results for its fourth quarter and fiscal year 2024, ended February 29, 2024 (“fiscal year 2024”). Fiscal Year 2024 Highlights Backlog at fiscal year-end on February 29, 2024, was $9.1 million, a 7% increase year over year, continuing a trend of strong backlog growth. Record net sales for fiscal year 2024 increased 31% to $19.7 million from $15.1 million in the prior year. Gross profit increased 29% to $9.8 million for fiscal year 2024 compared with $7.7 million for fiscal year 2023. The gross profit margin decreased slightly from 50.8% to 50% compared to the previous fiscal year due to product mix changes and recharacterization of expenses associated...

Continue reading

Apogee Therapeutics to Participate in Upcoming June Investor Conferences

SAN FRANCISCO and WALTHAM, Mass., May 23, 2024 (GLOBE NEWSWIRE) — Apogee Therapeutics, Inc. (Nasdaq: APGE), a clinical-stage biotechnology company advancing differentiated biologics for the treatment of atopic dermatitis, COPD, asthma and other inflammatory and immunology indications, today announced that members of management will participate at the following upcoming investor conferences: Jefferies Global Healthcare Conference Date: Thursday, June 6, 2024Time: 8:30 a.m. ET Goldman Sachs 45th Annual Global Healthcare ConferenceDate: Monday, June 10, 2024Time: 11:20 a.m. ET A live and archived webcast of the fireside chat and presentation will be available via the News & Events page in the Investors section of the Apogee Therapeutics website. About Apogee Therapeutics Apogee Therapeutics is a clinical-stage biotechnology company...

Continue reading

Rakovina Therapeutics Announces $1.5 million Non-Brokered Private Placement

All monetary figures listed in Canadian Dollars. VANCOUVER, British Columbia, May 23, 2024 (GLOBE NEWSWIRE) — Rakovina Therapeutics Inc. (TSX-V: RKV, the “Company” or “Rakovina Therapeutics”) a biopharmaceutical company committed to advancing new cancer therapies based on novel DNA-damage response technologies is pleased to announce the undertaking of a non-brokered Private Placement (the “Offering”) for gross proceeds of up to $1.5 million at a purchase price of $0.10 per Unit. This includes lead orders totalling approximately $1.25 million from two new investors. Each Unit will be comprised of one (1) common share of Rakovina Therapeutics common share stock and one (1) share purchase warrant at a purchase price of $0.20 for a period of three years (36 months) after the closing date of the Offering. If the closing price for the...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.